In the midst of a devastating epidemic of opioid abuse and misuse, a billionaire pharmaceutical maker has been granted a patent to treat opioid addiction, the Financial Times reported.

Speaking to a crowd at the University of Illinois, former President Barack Obama stated his support for "Medicare for All" last week.

In a new report, an association for the pharmaceutical industry has blamed rising healthcare costs on hospitals jacking up prices for prescription drugs.

The election in New Brunswick, Canada, is scheduled for later this month, and the leaders of the two largest political parties are making an identical promise: to ensure mammograms contain information about breast density.

Radiologists who are higher wage earners and more aware of the federal advocacy process are more likely to donate to radiology political action committees (PACs), according to recent research published in Current Problems in Diagnostic Radiology.

A new bill unanimously passed by the Senate Wednesday would prohibit Medicare insurers from preventing pharmacies from telling consumers if their prescription drugs are cheaper if they pay out of pocket versus through their insurance.

In the middle of a national opioid epidemic, one major health insurance provider has decided it will no longer cover OxyContin prescriptions next year.

When using the American College of Radiology’s Breast Imaging-Reporting and Data System (BI-RADS) to classify a breast lesion, radiologists are expected to only use the category 5 assessment when the likelihood of malignancy, or positive predictive value (PPV), is at least 95 percent. Is that a feasible expectation?